Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 72789-073

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 72789-073). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789073 Label (72789073)

72789073 Label (72789073)
This is a medication containing Cyclobenzaprine Hydrochloride in the form of tablets. The usual adult dosage is one tablet of 5mg taken three times a day, although detailed dosage recommendations can be found in the package outsert. The medicine must be stored in a well-closed container as defined in the USP with child-resistant closure and kept at a controlled room temperature between 20°C and 25°C. The medication is available in a pack of 30 tablets, manufactured and packaged by PD-Rx Pharmaceuticals, Inc, located in Oklahoma City. The manufacturing of the medication is carried out by Prinston Laboratories located in Charlotte. The global trade item number of the medication is 00372789073309, with a serial number of E21F19000115. The medication's expiry date is May 2023, and it should be kept out of children's reach.*
FDA Label Image

Structural Formula For Cyclobenzaprine. (Cyclobenzaprine 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.